| Structure |
Chemical Name |
CAS |
MF |
![1-[4-(4-AMino-6,7-diMethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone](/CAS/GIF/109678-71-9.gif) |
1-[4-(4-AMino-6,7-diMethoxy-2-quinazolinyl)-1-piperazinyl]-5-hydroxy-1-pentanone |
109678-71-9 |
C19H27N5O4 |
 |
Pralatrexate Impurity 8 |
112408-16-9 |
C8H15NO4 |
 |
Oseltamivir Impurity 15 |
2254819-34-4 |
C22H36N2O4 |
 |
Ethacridine Impurity 12 |
|
|
 |
Posaconazole Impurity 24 |
165115-78-6 |
C19H20F2O2 |
 |
Lamivudine Impurity 7 |
147126-63-4 |
C14H24O4S |
 |
ブロモベンザロン |
94729-09-6 |
C17H13BrO3 |
 |
Meropenem IMP B |
|
|
 |
Copper sulfate solution (CuSO4)=20%(wt) |
|
|
 |
1-methylpyrrolidin-3-yl 2-(4-chlorophenyl)-2-cyclopentyl- 2-hydroxyacetate hydrochloride |
|
|
 |
Mupirocin Impurity D |
|
C26H44O9 |
 |
Fasudil iMpurity C |
|
|
![1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-](/CAS/20211123/GIF/2102675-40-9.gif) |
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)- |
2102675-40-9 |
C17H19N5O2 |
 |
6,6'-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one |
1365727-09-8 |
C29H26N2O2 |
 |
myricetin 3-O-β-D-xylopyranosyl(1-2)-β-D-glucopyranoside |
142449-93-2 |
C26H28O17 |
 |
Gimeracil Impurity |
17902-24-8 |
C8H9ClN2O3 |
 |
Landiolol impurity Z |
|
|
 |
Indacaterol IMrity |
1235445-80-3 |
C24H28N2O3 |
 |
(S)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl) ethyl)-5,6-dihydro-2H-pyran-2-one |
|
|
 |
Amifostine Impurity 1 |
|
|
 |
テルミサルタン-D3 |
1189889-44-8 |
C33H27D3N4O2 |
 |
Rabeprazole Impurity 15 |
|
|
 |
2-アミノ-2-(4-ヘプチルフェネチル)-1,3-プロパンジオール |
745767-97-9 |
C18H31NO2 |
![2-(4-ethylpiperazin-1-yl)-4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](/CAS/20181212/GIF/CB810019553.gif) |
2-(4-ethylpiperazin-1-yl)-4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |
|
C23H30FN3 |
 |
Acarbose Impurity IV (JP) |
|
C13H21NO7 |
 |
Trelagliptin Impurity 2 |
|
|
 |
Crisaborole Impurity 15 |
|
|
 |
N-(3,4-dichlorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine |
2089650-13-3 |
C22H24Cl2N4O3 |
 |
3-propylisobenzofuran-1(3H)-one |
72424-08-9 |
C11H12O2 |
 |
Febuxostat Acyl-β-D-glucuronide |
1351692-92-6 |
C22H24N2O9S |
 |
Avibactam Impurity 15 |
1416134-60-5 |
C15H20N2O3 |
 |
Afatinib Impurity 16 |
|
|
 |
Cefodizime Impurity E |
|
|
 |
Iguratimod Impurity 9 |
1179354-65-4 |
C18H16N2O6S |
 |
Tazobactam Impurity DBT |
|
|
 |
Aprepitant Impurity 33 |
502537-39-5 |
C20H20F7NO3 |
![(5R,6S)-6-((R)-1-hydroxyethyl)-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-en-7-one](/) |
(5R,6S)-6-((R)-1-hydroxyethyl)-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-en-7-one |
|
|
 |
Gefitinib Impurity T |
|
|
 |
Bimatoprost Impurity S |
|
|
 |
ETHYL 2-CYCLOHEXYL-2-HYDROXY-PHENYLACETATE |
31197-69-0 |
C16H22O3 |
 |
7-PACE Impurity 2 |
|
|
 |
Ticagrelor Impurity 16 |
|
|
 |
Topiroxostat Impurity Ⅱ-3 |
|
|
 |
Erlotinib Hydrochloride iMpurity 50 |
|
|
 |
sofosBuvir impurity 49 |
|
|
 |
5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2- oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)isophthalonitrile |
|
|
 |
AtracuriuM Besylate IMpurity D Iodide (Mixture of DiastereoMers) |
|
|
 |
Apremilast Impurity 34 |
2469037-82-7 |
C20H20N2O7S |
 |
1,3-ビス(9H-カルバゾール-4-イルオキシ)-2-プロパノール(CARVEDILOL IMPURITY) |
1276477-91-8 |
C27H22N2O3 |
 |
Asparagine Impurity 48 |
2260823-58-1 |
C15H23NO6 |
 |
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
289472-81-7 |
C19H24N4O3 |
 |
9(10H)-Acridinone, 2-ethoxy-6-nitro- |
451460-48-3 |
C15H12N2O4 |
 |
Benzenediazonium, 4-(ethoxycarbonyl)-, chloride |
2028-79-7 |
C9H9ClN2O2 |
 |
Ethyl 3,4-O-isopropylideneshikiMate |
136994-78-0 |
C12H18O5 |
![Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester](/CAS/20210305/GIF/141354-54-3.gif) |
Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester |
141354-54-3 |
C9H9BrN2O3 |
 |
2-(1-(dimethylamino)ethyl)phenol 2,3-dihydroxysuccinate |
26050-44-2 |
C10H15NO |
 |
Dacpomycin Impurity 2 |
|
|
 |
Diquafosol Impurity 12 |
694434-51-0 |
C18H26N4O23P4 |
 |
Ticagrelor Impurity 68 |
1643378-46-4 |
C23H29FN6O4S |
 |
Nirmatrelvir Impurity 8 |
|
|
 |
Escitalopram Impurity |
91283-87-3 |
C18H14FNO3 |
 |
プソイドモン酸D |
85248-93-7 |
C26H42O9 |
![1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/CAS/20180703/GIF/743460-48-2.gif) |
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
743460-48-2 |
C21H27N3O2 |
 |
32,43,50-Tricarboxy-cyanoco balamin |
|
|
 |
Valsartan Impurity 1 |
914465-68-2 |
C19H21N5O |
 |
Entecavir Impurity 6 |
1354695-82-1 |
C26H27N5O3 |
 |
Paxlovid Impurity 11 |
|
|
 |
Loratadine Impurity I |
133330-56-0 |
C22H21ClN2O2 |
 |
Dapoxetine Impurity 17 |
|
|
 |
(2R,3R)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)-N-(4-methyl-3-(trifluoromethyl)phenyl)piperidine-3-carboxamide |
|
|
 |
Olsalazine Impurity D |
|
|
 |
Brexpiprazole Impurity 20 |
1420987-85-4 |
C20H20N2S2 |
 |
(R)-N-(1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo- 1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)formamide |
2087874-91-5 |
C19H20FN5O3 |
 |
Rasagiline Impurity 3 |
1175018-74-2 |
C12H14ClN |
![8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one](/CAS/20180629/GIF/1376615-91-6.gif) |
8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one |
1376615-91-6 |
C24H31N7O2 |
 |
Diquafosol Impurity 1 |
26184-65-6 |
C18H24N4O17P2 |
 |
Pinocembroside,Pinocembrin41-O-beta-D-glucoside |
|
|
 |
Fesoterodine Impurity 12 |
|
|
![1-メチル-12-チオキソピリド[1,2,3,4]イミダゾール-[1,2-A]ベンズイミダゾール-2(12H)-オン](/CAS/GIF/1246819-06-6.gif) |
1-メチル-12-チオキソピリド[1,2,3,4]イミダゾール-[1,2-A]ベンズイミダゾール-2(12H)-オン |
1246819-06-6 |
C14H9N3OS |
 |
Olaparib impurity 1 |
763113-06-0 |
C24H24N4O3 |
 |
Hydroxy TorseMide |
99300-68-2 |
C16H20N4O4S |
 |
Isavuconazole Impurity 34 |
|
|
 |
Erlotinib impurity A |
183321-85-9 |
C21H20ClN3O3 |
 |
ジゴキソシド |
31539-05-6 |
C47H74O17 |
 |
(S)-tert-butyl (1-(3-(2-cyanobenzyl) |
1618644-31-7 |
C23H29N5O4 |
 |
Lincomycin sulfone Impurity 2 |
|
|
 |
Clopidogrel Impurity 12 |
|
C15H14ClNO2S |
 |
ceftazidiMe iMpurity E |
|
|
![1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-](/CAS/20180629/GIF/138168-36-2.gif) |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]- |
138168-36-2 |
C18H34N4O9 |
 |
1H-Pyrazole,3-ethoxy-5-methyl-1-phenyl-(9CI) |
300543-31-1 |
C12H14N2O |
 |
Alvimopan Impurity 5 |
|
|
![2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID](/CAS/GIF/60091-87-4.gif) |
2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID |
60091-87-4 |
C13H9ClN2O4 |
 |
Bumetanide Impurity 23 |
|
|
 |
Tafluprost Impurity E |
|
|
 |
Teneligliptin Impurity 9 DiHCl |
|
|
 |
Nintedanib Impurity 26 |
|
|
 |
methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate |
1638785-19-9 |
C13H15ClO3 |
 |
Valsartan Impurity 12 |
1189547-11-2 |
C11H21NO3 |
 |
Sunitinib Impurity 4 |
|
|
 |
2-(1,3,2-Dioxaborinan-2-yl)benzamide |
2377611-18-0 |
C10H12BNO3 |